Approval · Notice of Compliance 12015 · 2011
SUMATRIPTAN SUN INJECTION: Notice of Compliance 12015
Issued January 20, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12015
- Date
- January 20, 2011
- Company
- Sun Pharma Global Fze
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- 5-HT1 receptor agonist
- Canadian reference product
- IMITREX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUMATRIPTAN SUN INJECTION | 02361698 | Marketed |
Medicinal ingredients
- SUMATRIPTAN SUCCINATE 6 MG per 0.5ML